Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, 117600, Singapore.
Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, 117599, Singapore.
Drug Discov Today. 2018 May;23(5):1043-1052. doi: 10.1016/j.drudis.2017.11.009. Epub 2017 Nov 16.
Nanoscale drug delivery systems or nanocarriers have shown tremendous promise in the target-specific delivery of therapeutics as well as diagnostic agents. Additional properties can be introduced into nanocarriers to enhance the bioavailability and targeting efficiency of the transported drugs at diseased sites. Such nanocarriers are usually incorporated with stimuli-responsive components that can be triggered by specific stimuli (e.g., temperature, pH, or enzymes) and further induced by certain biological responses, such as enzyme hydrolysis and molecular conformational changes, leading to the controlled release of the transported molecules at targeted sites. In this review, we discuss various stimuli-responsive nanoscale delivery systems and summarize the current perspectives as well as challenges facing the successful translation of these innovative stimuli-responsive nanocarriers from the bench to the bedside.
纳米药物递送系统或纳米载体在治疗药物和诊断试剂的靶向递送上显示出巨大的潜力。可以向纳米载体中引入附加性质,以提高病变部位输送药物的生物利用度和靶向效率。此类纳米载体通常与响应性组件结合使用,这些组件可被特定刺激(如温度、pH 值或酶)触发,并进一步受到某些生物学反应的诱导,如酶解和分子构象变化,从而导致在靶向部位控制释放输送的分子。在本文综述中,我们讨论了各种响应性纳米递药系统,并总结了将这些创新性响应性纳米载体从实验室转化到临床应用所面临的现状和挑战。